Primary culture of umbilical cord-derived mesenchymal stem cells in serum free medium

doi:10.3969/j.issn.2095-4344.2013.27.006

Abstract

Abstract:

BACKGROUND: The application of mesenchymal stem cells derived from umbilical cord cultured in serum-containing medium has some obstacles.
OBJECTIVE: To establish serum free medium system for primary culture of umbilical cord-derived mesenchymal stem cells.
METHODS: Wharton’s Jelly was isolated from umbilical cord, minced, 1-3 mm3, and subsequently incubated in either serum containing medium or serum free medium. Some cells were harvested on days 11, 14 and 17 for some detection. Based on the minimal criteria established by the International Society for Cellular Therapy in 2006, mesenchymal stem cells were assayed with colony forming unit-fibroblast.
RESULTS AND CONCLUSION: The mesenchymal stem cells grew rapidly in serum free medium condition compared with serum containing medium. On day 11, the number of colonies was larger in serum free medium condition than that in serum containing medium. Thus, serum free medium could maintain properties of mesenchymal stem cells and provide possibility a credible alternative to serum containing medium for primary culture of umbilical cord-derived mesenchymal stem cells.

Key words: stem cells, umbilical cord blood-derived stem cells, umbilical cord-derived mesenchymal stem cells, primary culture, serum free, serum containing, replacing, colony forming unit, National Natural Science Foundation of China, stem cell photographs-containing paper

CLC Number:

R394.2

Zhou Ting-ting, Wei Chao, Chen Xiao-dong, Li Hai, Wang Zheng. Primary culture of umbilical cord-derived mesenchymal stem cells in serum free medium[J]. Chinese Journal of Tissue Engineering Research, doi: 10.3969/j.issn.2095-4344.2013.27.006.

Figures/Tables 5

References

[1] Dennis JE, Merriam A, Awadallah A,et al.A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse.J Bone Miner Res. 1999;14(5):700-709.

[2] Ferrari G, Cusella-De Angelis G, Coletta M,et al.Muscle regeneration by bone marrow-derived myogenic progenitors.Science. 1998;279(5356):1528-1530.

[3] Liu S, Yuan M, Hou K,et al.Immune characterization of mesenchymal stem cells in human umbilical cord Wharton's jelly and derived cartilage cells.Cell Immunol. 2012;278(1-2):35-44.

[4] Ma L, Zhou Z, Zhang D,et al.Immunosuppressive function of mesenchymal stem cells from human umbilical cord matrix in immune thrombocytopenia patients.Thromb Haemost. 2012; 107(5):937-950.

[5] Zhang YK, Han XY, Che ZY. Effects of buyang huanwu tang combined with bone marrow mesenchymal stem cell transplantation on the expression of VEGF and Ki-67 in the brain tissue of the cerebral ischemia-reperfusion model rat.J Tradit Chin Med. 2010;30(4):278-282.

[6] Motaln H, Gruden K, Hren M,et al. Human Mesenchymal Stem Cells Exploit the Immune Response Mediating Chemokines to Impact the Phenotype of Glioblastoma.Cell Transplant. 2012. [Epub ahead of print]

[7] Ji YR, Yang ZX, Han ZB,et al. Mesenchymal Stem Cells Support Proliferation and Terminal Differentiation of B Cells.Cell Physiol Biochem. 2012;30(6):1526-1537.

[8] McGuirk JP, Weiss ML. Promising cellular therapeutics for prevention or management of graft-versus-host disease (a review).Placenta. 2011;32 Suppl 4:S304-310.

[9] Mathiasen AB, Jørgensen E, Qayyum AA,et al. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).Am Heart J. 2012;164(3):285-291.

[10] Kim SM, Woo JS, Jeong CH,et al. Effective combination therapy for malignant glioma with TRAIL-secreting mesenchymal stem cells and lipoxygenase inhibitor MK886.Cancer Res. 2012;72(18):4807-4817.

[11] Friedenstein AJ, Petrakova KV, Kurolesova AI,et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues.Transplantation. 1968; 6(2):230-247.

[12] Deng Y, Li TQ, Yan YE,et al. Effect of nicotine on chondrogenic differentiation of rat bone marrow mesenchymal stem cells in alginate bead culture. Biomed Mater Eng. 2012;22(1-3):81-87.

[13] Leng Y, Zheng Z, Zhou C,et al. A comparative study of bone marrow mesenchymal stem cell functionality in C57BL and mdx mice.Neurosci Lett. 2012;523(2):139-144.

[14] Guo QS, Zhu MY, Wang L,et al. Combined transfection of the three transcriptional factors, PDX-1, NeuroD1, and MafA, causes differentiation of bone marrow mesenchymal stem cells into insulin-producing cells.Exp Diabetes Res. 2012; 2012:672013.

[15] Al Faqeh H, Nor Hamdan BM, Chen HC,et al.The potential of intra-articular injection of chondrogenic-induced bone marrow stem cells to retard the progression of osteoarthritis in a sheep model.Exp Gerontol. 2012;47(6):458-464.

[16] Grove JE, Bruscia E, Krause DS. Plasticity of bone marrow-derived stem cells.Stem Cells. 2004;22(4):487-500.

[17] Pietilä M, Lähteenmäki K, Lehtonen S,et al. Monitoring mitochondrial inner membrane potential for detecting early changes in viability of bacterium-infected human bone marrow-derived mesenchymal stem cells.Stem Cell Res Ther. 2012;3(6):53.

[18] Yagi H, Tan J, Tuan RS. Polyphenols suppress hydrogen peroxide-induced oxidative stress in human bone-marrow derived mesenchymal stem cells. J Cell Biochem. 2012. [Epub ahead of print]

[19] Kocsis JD, Honmou O.Bone marrow stem cells in experimental stroke. Prog Brain Res. 2012;201:79-98.

[20] Iwamoto T, Terai S, Hisanaga T,et al.Bone-marrow-derived cells cultured in serum-free medium reduce liver fibrosis and improve liver function in carbon-tetrachloride-treated cirrhotic mice.Cell Tissue Res. 2012. [Epub ahead of print]

[21] Wei T, Lv Y. Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs.Hepatology. 2012. [Epub ahead of print]

[22] Lu LL, Liu YJ, Yang SG,et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 2006;91(8):1017-1026.

[23] Prockop DJ. Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms.Mol Ther. 2009;17(6):939-946.

[24] Zhang X, Zhang L, Xu W,et al. Experimental therapy for lung cancer: umbilical cord-derived mesenchymal stem cell-mediated interleukin-24 delivery.Curr Cancer Drug Targets. 2013;13(1):92-102.

[25] Hu J, Yu X, Wang Z,et al. Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. Endocr J. 2012. [Epub ahead of print]

[26] Liu R, Zhang Z, Lu Z,et al. Human Umbilical Cord Stem Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Immunoinflammation and Remyelination.Stem Cells Dev. 2012. [Epub ahead of print]

[27] Xue G, He M, Zhao J, et al. Intravenous umbilical cord mesenchymal stem cell infusion for the treatment of combined malnutrition nonunion of the humerus and radial nerve injury.Regen Med. 2011;6(6):733-741.

[28] Kim J, Shin JM, Jeon YJ,et al. Proteomic validation of multifunctional molecules in mesenchymal stem cells derived from human bone marrow, umbilical cord blood and peripheral blood. PLoS One. 2012;7(5):e32350.

[29] Meng MY, Pang W, Jiang LH,et al. Stemness gene expression profile analysis in human umbilical cord mesenchymal stem cells.Exp Biol Med (Maywood). 2012;237(6):709-719.

[30] Wang D, Ji YR, Chen K,et al. IL-6 production stimulated by CD14(+) monocytes-paracrined IL-1β does not contribute to the immunosuppressive activity of human umbilical cord mesenchymal stem cells.Cell Physiol Biochem. 2012;29(3-4): 551-560.

[31] Manochantr S, U-Pratya Y, Kheolamai P,et al. Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord.Intern Med J. 2012. [Epub ahead of print]

[32] Zhang Y, Hao H, Liu J,et al. Repair and regeneration of skin injury by transplanting microparticles mixed with Wharton's jelly and MSCs from the human umbilical cord. Int J Low Extrem Wounds. 2012;11(4):264-270.

[33] Salehinejad P, Alitheen NB, Ali AM,et al.Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly.In Vitro Cell Dev Biol Anim. 2012;48(2):75-83.

[34] Montanucci P, Basta G, Pescara T,et al. New simple and rapid method for purification of mesenchymal stem cells from the human umbilical cord Wharton jelly.Tissue Eng Part A. 2011; 17(21-22):2651-2661.

[35] Tsagias N, Koliakos I, Karagiannis V,et al. Isolation of mesenchymal stem cells using the total length of umbilical cord for transplantation purposes.Transfus Med. 2011;21(4): 253-261.

[36] Lai Y, Sun Y, Skinner CM,et al. Reconstitution of marrow-derived extracellular matrix ex vivo: a robust culture system for expanding large-scale highly functional human mesenchymal stem cells.Stem Cells Dev. 2010;19(7):1095-1107.

[37] Javazon EH, Beggs KJ, Flake AW. Mesenchymal stem cells: paradoxes of passaging. Exp Hematol. 2004;32(5):414-425.

[38] Bowen MA, Aruffo AA, Bajorath J. Cell surface receptors and their ligands: in vitro analysis of CD6-CD166 interactions. Proteins. 2000;40(3):420-428.

[39] Tsai MS, Lee JL, Chang YJ,et al. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol.Hum Reprod. 2004;19(6):1450-1456.

[40] Dominici M, Le Blanc K, Mueller I,et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317.

[41] Sorrentino A, Ferracin M, Castelli G,et al. Isolation and characterization of CD146+ multipotent mesenchymal stromal cells.Exp Hematol. 2008;36(8):1035-1046.

[42] Gang EJ, Bosnakovski D, Figueiredo CA, et al. SSEA-4 identifies mesenchymal stem cells from bone marrow.Blood. 2007;109(4):1743-1751.

[43] Ouhtit A, Gaur RL, Abd Elmageed ZY,et al. Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146.Biochim Biophys Acta. 2009;1795 (2):130-136.

[44] Battula VL, Treml S, Bareiss PM,et al. Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1.Haematologica. 2009;94(2):173-184.

[45] Li W, Ren G, Huang Y,et al. Mesenchymal stem cells: a double-edged sword in regulating immune responses.Cell Death Differ. 2012;19(9):1505-1513.

[46] Pelosi E, Castelli G, Testa U. Human umbilical cord is a unique and safe source of various types of stem cells suitable for treatment of hematological diseases and for regenerative medicine. Blood Cells Mol Dis. 2012;49(1):20-28.

[47] Selvaggi TA, Walker RE, Fleisher TA. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions.Blood. 1997;89(3):776-779.

[48] Tonti GA, Mannello F. From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera.Int J Dev Biol. 2008;52(8): 1023-1032.

[49] Chachques JC, Herreros J, Trainini J,et al. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty.Int J Cardiol. 2004;95 Suppl 1:S29-33.

[50] Mizuno N, Shiba H, Ozeki Y,et al. Human autologous serum obtained using a completely closed bag system as a substitute for foetal calf serum in human mesenchymal stem cell cultures.Cell Biol Int. 2006;30(6):521-524.